ATC code D05

In today's world, ATC code D05 is a topic that occupies a central place in conversations and debates in society. Whether in terms of social, economic, political or cultural impact, ATC code D05 has captured the attention of people of all ages and walks of life. The relevance and importance of ATC code D05 extends globally, and its influence is felt in different areas of daily life. In this article, we will explore the different facets and perspectives surrounding ATC code D05, with the aim of deeply understanding its scope and its implications for the present and the future.
ATC code D: Dermatologicals
ATCvet only
Other ATC codes

ATC code D05 Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D05 is part of the anatomical group D Dermatologicals.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".

D05A Antipsoriatics for topical use

In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".

D05AA Tars

D05AC Antracen derivatives

D05AC01 Dithranol
D05AC51 Dithranol, combinations

D05AD Psoralens for topical use

D05AD01 Trioxysalen
D05AD02 Methoxsalen

D05AX Other antipsoriatics for topical use

In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".
D05AX01 Fumaric acid
D05AX02 Calcipotriol
D05AX03 Calcitriol
D05AX04 Tacalcitol
D05AX05 Tazarotene
D05AX06 Roflumilast
D05AX07 Tapinarof
D05AX52 Calcipotriol, combinations
D05AX55 Tazarotene and ulobetasol

D05B Antipsoriatics for systemic use

In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".

D05BA Psoralens for systemic use

D05BA01 Trioxysalen
D05BA02 Methoxsalen
D05BA03 Bergapten

D05BB Retinoids for treatment of psoriasis

D05BB01 Etretinate
D05BB02 Acitretin

D05BX Other antipsoriatics for systemic use

In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".
D05BX51 Fumaric acid derivatives, combinations

References

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code D05". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QD05". WHO Collaborating Centre for Drug Statistics Methodology.
Wikious
Boobota
Sagapedia